Biased Expression of the FOXP3 3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-2581
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2016
Authors
Publisher
American Association for Cancer Research (AACR)